Associations between genetically predicted plasma N-glycans and pancreatic cancer risk

Duo Liua Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of China;b Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USAView further author information

Tianying Zhaob Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA;c Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, USAView further author information

Jingjing Zhub Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USAView further author information

Sodbo Sharapovd MSU Institute for Artificial Intelligence, Lomonosov Moscow State University, Moscow, RussiaView further author information

Evgeny Tiyse Laboratory of Glycogenomics, Institute of Cytology and Genetics, Novosibirsk, RussiaView further author information

Lang Wub Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USACorrespondence[email protected]
View further author information

Associations between genetically predicted plasma N-glycans and pancreatic cancer risk

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Associations between genetically predicted plasma N-glycans and pancreatic cancer risk

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date